← Back to list

iShares Nasdaq US Biotechnology UCITS ETF

Nasdaq Biotechnology

Equities
ISIN
IE00BYXG2H39
Issuer
iShares
TER
0.35%
Latest closing price
N/A
Fund Size
€977 m As of: Sep 30, 2026
Domicile
Ireland
Distribution Policy
Accumulating
Replication Method
Physical
Base Currency
USD
WKN / Ticker
A2DWAW / 2B70
Cheapest of 3 ETFs tracking the Nasdaq Biotechnology (by TER).

Data availability

Data is available for 2 of 5 areas for this fund.

  • Master data (TER, index, size): As of: Sep 30, 2026
  • Closing price: not available
  • Price history (at least 20 prices): not available
  • Holdings: As of: Jul 30, 2026
  • Risk figures: not available

Missing information is marked as “not available” and is not estimated. The issuer’s documents are authoritative.

At a glance

iShares Nasdaq US Biotechnology UCITS ETF (ISIN IE00BYXG2H39) is a fund from iShares (fund type: ETF). Benchmark index: Nasdaq Biotechnology. Its ongoing charges (TER) are 0.35% per year. The fund size is €977 m. Distribution policy: Accumulating. Replication: Physical. Fund domicile: Ireland.

Key Facts
  • Launch date 19.10.2017 (8 years)
  • Number of Holdings 250
  • Strategy Passive (index tracking)
  • Base Currency USD
  • Currency hedging No
  • Distribution Policy Accumulating
  • Replication Method Physical
  • Securities lending Yes
  • Domicile IE
  • UCITS Compliant Yes

Price development

Error loading comparison.
There is not enough price data available for this period yet.

Pure price change based on stored closing prices; distributions, purchase costs and taxes are not included. Different currencies and index types (price or total return index) can distort the comparison line. Past performance is not a reliable indicator of future results.

Risk figures (12 months)

No calculated risk figures are available for this fund yet.

The official summary risk indicator (SRI, scale 1–7) is in the issuer’s key information document (KID). The figures here are historical values and do not replace it.

Documents

We have no documents stored for this fund. The key information document (KID), factsheet and prospectus are provided by the issuer.

Search documents at iShares

Tracking difference and tracking error

We have no comparison series stored for this fund’s index, so a tracking analysis is not possible.

What does the fund invest in?
As of 10.09.2026 · Source: justETF / etfdb
Sector Breakdown
  • Health care 99.8%
  • Cash 0.2%
Country Breakdown
  • United States 92.9%
  • Belgium 1.9%
  • Denmark 1.2%
  • France 1.1%
  • China 0.9%
  • Germany 0.8%
  • United Kingdom 0.3%
  • Canada 0.2%
  • Netherlands 0.2%
  • Ireland 0.1%
  • All others 0.3%

Holdings

Showing 10 holdings that together make up 41.6 % of fund assets. (out of 250 holdings in total).

# Name ISIN Sector Country Weight
1 Amgen, Inc. US0311621009 – – 8.47 %
2 Vertex Pharmaceuticals US92532F1003 – – 7.92 %
3 Gilead Sciences, Inc. US3755581036 – – 7.19 %
4 Regeneron Pharmaceuticals, Inc. US75886F1075 – – 5.34 %
5 Revolution Medicines US76155X1000 – – 2.87 %
6 Illumina, Inc. US4523271090 – – 2.18 %
7 Biogen US09062X1037 – – 2.15 %
8 Alnylam Pharmaceuticals US02043Q1076 – – 1.93 %
9 Royalty Pharma GB00BMVP7Y09 – – 1.84 %
10 Roivant Sciences Ltd. BMG762791017 – – 1.74 %
Cost calculator
What does this ETF cost you per year – and over your whole investment horizon?
Cost in year 1
–
Total cost impact
–

Simplified model based on the TER, excluding order fees, spreads, taxes and tracking difference. Not investment advice.

Alternatives on the same index
Other ETFs tracking the Nasdaq Biotechnology – cheapest first.
Name TER Fund Volume Distribution
iShares Nasdaq US Biotechnology UCITS ETF This fund 0.35% €977 m Accumulating
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.35% €72 m Distributing
Invesco Nasdaq Biotech UCITS ETF 0.40% €410 m Accumulating
Compare in detail

Frequently asked questions about the iShares Nasdaq US Biotechnology UCITS ETF

The total expense ratio (TER) of the iShares Nasdaq US Biotechnology UCITS ETF is 0.35% per year. The costs are deducted from the fund assets on an ongoing basis and are already reflected in its performance.

The iShares Nasdaq US Biotechnology UCITS ETF tracks the Nasdaq Biotechnology. Our index encyclopedia explains the index and lists all funds that track it.

The iShares Nasdaq US Biotechnology UCITS ETF is accumulating: income such as dividends is not paid out but automatically reinvested in the fund.

The iShares Nasdaq US Biotechnology UCITS ETF uses physical replication: it holds the securities of the index directly – either in full or as a representative sample (sampling).

The fund size of the iShares Nasdaq US Biotechnology UCITS ETF is €977 m. A large fund size usually indicates good tradability and a lower risk of the fund being closed.

The iShares Nasdaq US Biotechnology UCITS ETF is domiciled in Ireland. The fund domicile affects, among other things, how withholding taxes are treated inside the fund.

The provider (issuer) of the iShares Nasdaq US Biotechnology UCITS ETF is iShares.

All information without guarantee. It is provided for information purposes only and does not constitute investment advice.